Chester County News and Community Website
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) has fortified its intellectual property holdings with the United States Patent and Trademark Office’s issuance of a new patent for ZTALMY® (ganaxolone) oral …
Marinus Pharmaceuticals Expands Intellectual Property Portfolio with New ZTALMY® Patent Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) released new guidelines aimed at improving treatment options for young children with partial onset seizures (POS). The guidance, titled …
FDA Issues New Guidance on Epilepsy Drugs for Young Children Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), announced key data today from two separate preclinical studies. The data provides fascinating insights into the potential effects of TRV045, a novel S1P1 …
Revolutionary Preclinical Data Unveiled by Trevena: Potential New Direction in Neuropathic Pain and Acute Seizure Management Read More RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) recently announced its decision to proceed with the Phase 3 RAISE trial of intravenous (IV) ganaxolone for treating refractory status epilepticus (RSE), …
Marinus Pharmaceuticals Continues Phase 3 Trial for Epilepticus Treatment Despite Setback Read More